DESTIN, Fla. — Multiple potentially new therapies promise to improve the management of patients with Sjgren’s syndrome, according to a speaker at the 2023 Congress of Clinical Rheumatology meeting.These advancements follow years of researchers struggling to repurpose existing drugs to fit the needs of patients with the disease.